Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.

Biotechnology

Mozart Therapeutics

Katie Fanning

Russ Hawkinson

Jennifer More

Courtney Crane

Kristine Swiderek

The Scientific Advisory Team at Mozart Therapeutics provides expert guidance on the research, development, and strategic direction of the company's CD8 Treg modulator therapies. Comprised of leading scientists and clinicians in the field of immunology, the team advises on cutting-edge scientific advancements and ensures the robustness and efficacy of Mozart’s therapeutic pipeline for autoimmune and inflammatory diseases.

Scientific Advisory Team

Directors Team

Research and Development

Leadership Team

Scientific Advisory Team

About

Team members

Other teams at Mozart Therapeutics

Directors Team

Research and Development

Leadership Team